• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型神经纤维瘤病患儿的肌肉无力

Muscle weakness in children with neurofibromatosis type 1.

作者信息

Cornett Kayla M D, North Kathryn N, Rose Kristy J, Burns Joshua

机构信息

Institute for Neuroscience and Muscle Research, The Children's Hospital at Westmead, Sydney, NSW, Australia.

Arthritis and Musculoskeletal Research Group, Faculty of Health Sciences, The University of Sydney, Sydney, NSW, Australia.

出版信息

Dev Med Child Neurol. 2015 Aug;57(8):733-6. doi: 10.1111/dmcn.12777. Epub 2015 Apr 23.

DOI:10.1111/dmcn.12777
PMID:25913846
Abstract

AIM

To investigate if children with neurofibromatosis type 1 (NF1) have reduced muscle strength compared with children with typical development.

METHOD

Maximal isometric strength of 15 upper and lower limb muscle groups was evaluated in 30 children with NF1 (16 males, 14 females; aged 4-16y) and 30 age-, sex-, height-, and weight-matched controls using hand-held dynamometry by a single evaluator. Both the left and right sides were assessed.

RESULTS

Children with NF1 were significantly weaker than children with typical development across all 15 muscle groups assessed (p<0.05). Apart from elbow flexion, there were no differences between the left and right sides (p>0.05). Magnitude of differences between the children with NF1 compared with the controls ranged from 3% to 43%. Males and females were equally affected.

INTERPRETATION

This study shows that children with NF1 have reduced muscle strength compared with children with typical development. This muscle weakness is present from the earliest stages of the disease assessed and persists throughout childhood with no sex difference. These results support recent evidence from mouse studies that NF1 is associated with a primary myopathy.

摘要

目的

研究1型神经纤维瘤病(NF1)患儿与发育正常儿童相比肌肉力量是否降低。

方法

由一名评估者使用手持测力计,对30名NF1患儿(16名男性,14名女性;年龄4 - 16岁)和30名年龄、性别、身高和体重匹配的对照组儿童的15个上下肢肌肉群的最大等长肌力进行评估。对左右两侧均进行评估。

结果

在评估的所有15个肌肉群中,NF1患儿明显比发育正常儿童虚弱(p<0.05)。除了肘关节屈曲外,左右两侧之间没有差异(p>0.05)。NF1患儿与对照组之间的差异幅度在3%至43%之间。男性和女性受影响程度相同。

解读

本研究表明,与发育正常儿童相比,NF1患儿肌肉力量降低。这种肌肉无力在疾病评估的最早阶段就已出现,并在整个童年期持续存在,无性别差异。这些结果支持了最近小鼠研究的证据,即NF1与原发性肌病有关。

相似文献

1
Muscle weakness in children with neurofibromatosis type 1.1型神经纤维瘤病患儿的肌肉无力
Dev Med Child Neurol. 2015 Aug;57(8):733-6. doi: 10.1111/dmcn.12777. Epub 2015 Apr 23.
2
Lower extremity strength and hopping and jumping ground reaction forces in children with neurofibromatosis type 1.儿童 1 型神经纤维瘤病的下肢力量和跳跃以及跳跃地面反作用力。
Hum Mov Sci. 2012 Feb;31(1):247-54. doi: 10.1016/j.humov.2011.05.004. Epub 2011 Sep 8.
3
Are muscles weaker in children with neurofibromatosis type 1?1型神经纤维瘤病患儿的肌肉是否更弱?
Dev Med Child Neurol. 2015 Aug;57(8):699. doi: 10.1111/dmcn.12782. Epub 2015 Apr 29.
4
Ankle strength and functional limitations in children and adolescents with type I osteogenesis imperfecta.I型成骨不全症儿童和青少年的踝关节力量及功能受限情况
Pediatr Phys Ther. 2010 Fall;22(3):288-95. doi: 10.1097/PEP.0b013e3181ea8b8d.
5
Muscular force is reduced in neurofibromatosis type 1.1型神经纤维瘤病患者的肌肉力量会减弱。
J Musculoskelet Neuronal Interact. 2009 Jan-Mar;9(1):15-7.
6
Ankle strength and functional limitations in children and adolescents with type I osteogenesis imperfecta.I型成骨不全症儿童和青少年的踝关节力量及功能受限情况
Pediatr Phys Ther. 2010 Fall;22(3):295. doi: 10.1097/PEP.0b013e3181eb6d35.
7
Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.手持式测力计测量 1 型和 2 型神经纤维瘤病局限性肌肉无力的可靠性。
Neurology. 2021 Aug 17;97(7 Suppl 1):S99-S110. doi: 10.1212/WNL.0000000000012439. Epub 2021 Jul 6.
8
Case-control study of the muscular compartments and osseous strength in neurofibromatosis type 1 using peripheral quantitative computed tomography.利用外周定量计算机断层扫描对1型神经纤维瘤病患者肌肉腔室与骨强度进行病例对照研究。
J Musculoskelet Neuronal Interact. 2005 Jun;5(2):145-9.
9
Involuntary and voluntary muscle activation in children with unilateral cerebral palsy--relationship to upper limb activity.儿童单侧脑瘫的不随意和随意肌肉激活——与上肢活动的关系。
Eur J Paediatr Neurol. 2013 May;17(3):274-9. doi: 10.1016/j.ejpn.2012.11.002. Epub 2012 Nov 29.
10
Postural control in children with and without neurofibromatosis type 1.
Hum Mov Sci. 2014 Apr;34:157-63. doi: 10.1016/j.humov.2014.01.008. Epub 2014 Mar 12.

引用本文的文献

1
The evolving landscape of NF gene therapy: Hurdles and opportunities.神经纤维瘤基因治疗的发展态势:障碍与机遇
Mol Ther Nucleic Acids. 2025 Feb 3;36(1):102475. doi: 10.1016/j.omtn.2025.102475. eCollection 2025 Mar 11.
2
NF1 miniswine model the cellular disruptions and behavioral presentations of NF1-associated cognitive and motor impairment.NF1 小型猪模型模拟了 NF1 相关认知和运动障碍的细胞紊乱和行为表现。
Clin Transl Sci. 2024 Jun;17(6):e13858. doi: 10.1111/cts.13858.
3
Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1).
饮食干预挽救了神经纤维瘤病 1 型 (NF1) 小鼠模型的骨质疏松表型。
PLoS One. 2024 Jun 24;19(6):e0304778. doi: 10.1371/journal.pone.0304778. eCollection 2024.
4
Characterization of health concerns in people with neurofibromatosis type 1.描述 1 型神经纤维瘤病患者的健康关注点。
Mol Genet Genomic Med. 2023 Jan;11(1):e2077. doi: 10.1002/mgg3.2077. Epub 2022 Nov 28.
5
The skeletal muscle phenotype of children with Neurofibromatosis Type 1 - A clinical perspective.神经纤维瘤病 1 型患儿的骨骼肌表型——临床视角。
J Musculoskelet Neuronal Interact. 2022 Mar 1;22(1):70-78.
6
Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.手持式测力计测量 1 型和 2 型神经纤维瘤病局限性肌肉无力的可靠性。
Neurology. 2021 Aug 17;97(7 Suppl 1):S99-S110. doi: 10.1212/WNL.0000000000012439. Epub 2021 Jul 6.
7
L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.左旋肉碱补充治疗 1 型神经纤维瘤病患儿肌肉无力和疲劳:一项 2a 期临床试验。
Am J Med Genet A. 2021 Oct;185(10):2976-2985. doi: 10.1002/ajmg.a.62392. Epub 2021 Jun 21.
8
Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.神经纤维瘤病基因(Nf1)在出生后肌肉肥大生长和代谢稳态中的细胞自主需求。
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1758-1778. doi: 10.1002/jcsm.12632. Epub 2020 Oct 19.
9
An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains.1型神经纤维瘤病的执行功能视角:从注意力缺陷多动障碍和自闭症谱系障碍到研究领域
Childs Nerv Syst. 2020 Oct;36(10):2321-2332. doi: 10.1007/s00381-020-04745-w. Epub 2020 Jul 3.